German drug maker Bayer AG spent more than $2 million in the first half of 2007 to lobby the federal government, according to a Congress disclosure form.
The company lobbied on numerous issues, including patent reform, energy and environmental legislation, drug safety measures, international trade and others, according to the form posted online Friday by the Senate's public records office.
Source
No comments:
Post a Comment